Get in touch
555-555-5555
mymail@mailservice.com
SSL collaborate with the University of Newcastle on Bioprinting Vision
1 October 2021
Working towards improved tissue functionality
In 2020, the University of Newcastle applied for a ESPRC project with Santorini Scientific as one of their partners. This was secured in 2021 and finally launched in January 2022.
The project is developing a 3D Bioprinting Head which would allow biological cells to be 3D printed with greater density, thus enabling great tissue functionality. Santorini Scientific’s contribution means that the first cells trialled for this revolutionary new 3D bioprinting technique will be cardiac cells.
Find out more, watch the video below to see a time-lapse of the HL-1 cells.
Video credit: Babis Tzivelekis at Newcastle University
Remodelling of the infarcted heart: piezoelectric multifunctional patch video release
Santorini Scientific Ltd and UWE Bristol announce new Accelerated Knowledge Transfer (AKT): Accelerating development of a multi-sensor, multi-culture cell model for evaluation of heart transplant rejection to enable personalised treatment
After a competitive process, project funding has been awarded by Innovate UK to Santorini Scientific for modelling rejection as a platform for future post-transplant therapies
Developing a model for analysing heart transplant patient data
SSL secured AHSN Network Grant in Collaboration with the University of The West of England
Santorini Scientific is participating in a European scientific study funded by Horizon Europe to help the 2 million people in Europe affected by heart disease every year
Non-invasive Diagnostics will reduce patients’ stress factors and infection risks
SSL is looking to purchase a 3D Bioprinter and technical support. Can you help? If so, please download and reply to our tender.
27 June 2022: ERDF funding under the KEEP+ programme to work with UWE
25 May 2022: Exploring TReg therapy to reduce post-transplant rejection